Evaluation of Evolocumab (AMG 145), a Fully Human Anti‐PCSK9 IgG2 Monoclonal Antibody, in Subjects With Hepatic ImpairmentJohn P. Gibbs, Maurice G. Emery, J. Greg Slatter et al.|The Journal of Clinical Pharmacology|2016Cited by 25